Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Century Sage Scientific Holdings Limited
世 紀 睿 科 控 股 有 限 公 司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 1450)
GRANT OF SHARE OPTIONS
This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (''Listing Rules'').
The board (the ''Board'') of directors (the ''Directors'') of Century Sage Scientific Holdings Limited (the ''Company'', together with its subsidiaries, the ''Group'') announces that on 10 September 2020, share options (the ''Options'') in respect of up to 7,000,000 ordinary shares of HK$0.01 each in the share capital of the Company (the ''Shares'') were granted to eligible employees (the ''Grantees''), pursuant to the share option scheme adopted by the Company on 13 June 2014 (the ''Share Option Scheme''), subject to the acceptance by the Grantees. The following are the details of the Options granted:
Date of grant
Number of underlying Shares being the subject of the Options granted
- 10 September 2020
- in respect of 7,000,000 Shares
Exercise price per Share under the | : | HK$0.067 | per | Share, | which | represents | the |
Options | highest of | (i) | the closing price | per Share | of | ||
HK$0.067 | on the date of grant, i.e. 10 | ||||||
September 2020; (ii) the average closing price | |||||||
of HK$0.0612 per Share as stated in the daily | |||||||
quotation sheets issued by The Stock Exchange | |||||||
of Hong Kong Limited for five business days | |||||||
immediately preceding | the date | of grant; | and |
- the nominal value of the Share, being HK$0.01
Closing price of the Shares on the | : | HK$0.067 per Share |
date of grant |
- 1 -
Exercise dates and validity period | : | The Options shall expire on the 10th anniversary |
of the Options | date of adoption of the Share Option Scheme | |
(i.e. 13 June 2024), or the earlier termination of | ||
the Options in accordance with the Share Option | ||
Scheme. Among the Options, 4,000,000 of the | ||
Options (''Director Options'') were granted to | ||
Mr. Li Jinping, an executive Director, and shall | ||
be exercisable from the 2nd anniversary of the | ||
date of grant (i.e. 10 September 2022). The | ||
remaining 3,000,000 of the Options shall be | ||
exercisable from the 3rd anniversary of the date | ||
of grant (i.e. 10 September 2023). |
The above grant of the Director Options has been approved by the independent non- executive Directors and is not subject to approval by shareholders of the Company under Rule 17.04(1) of the Listing Rules.
Save as disclosed above, none of the Grantees is a Director, chief executive or substantial shareholder of the Company, nor any of their respective associates (as defined under the Listing Rules) of any of them.
By order of the Board
Century Sage Scientific Holdings Limited
Lo Chi Sum
Chairman
Hong Kong, 10 September 2020
As at the date of this announcement, the executive Directors are Mr. Lo Chi Sum, Mr. Leung Wing Fai, Mr. Geng Liang and Mr. Li Jinping, and the independent non-executive Directors are Mr. Hung Muk Ming, Dr. Ng Chi Yeung, Simon, and Mr. Mak Kwok Wing.
- 2 -
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Century Sage Scientific Holdings Ltd. published this content on 10 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 September 2020 11:04:02 UTC